BOXL vs GSK · rev $109.2M vs P/E 13, $103.31B cap
Boxlight Corp Class A (BOXL) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Boxlight Corp Class A (BOXL) is a consumer electronics company listed on NASDAQ.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported BOXL revenue for 2025-12-31 was $109.2M. Net income was -$23.8M. Revenue was down 19.6% from 2024-12-31 to 2025-12-31. BOXL currently screens at market cap $2.7M.
GSK does not have a complete income-statement cache yet.
BOXL currently screens at market cap $2.7M. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the BOXL and GSK stock pages for the full models.
Not investment advice.